fbpx

Recall Changes on Valsartan, Losartan and Irbesartan

By |2019-05-09T13:30:55+00:00March 1st, 2019|Failure To Diagnose, Local News, Medical Malpractice, Medical Recalls, Uncategorized|

FDA updates on angiotensin II receptor blocker (ARB) recalls including valsartan, losartan and irbesartan IMPORTANT: Medications containing only amlodipine or hydrochlorothiazide (HCTZ) are not being recalled. Manufacturers are recalling medications containing amlodipine in combination with valsartan or losartan, and medications containing hydrochlorothiazide HCTZ in combination with valsartan or losartan. […]

If You Have Gout and Take This Medicine – You Need to Know This

By |2019-02-22T16:57:11+00:00February 22nd, 2019|Failure To Diagnose A Heart Attack, Failure To Properly Read X-rays And Mammograms, Medication Errors, Press Releases, Recalls|

FDA has concluded there is an increased risk of death with Uloric (febuxostat) compared to another gout medicine, allopurinol. This conclusion is based on our in-depth review of results from a safety clinical trial that found an increased risk of heart-related death and death from all causes with Uloric.

Lavern’s Law | Date of Discovery Bill

By |2018-12-19T19:43:54+00:00September 27th, 2017|Attorney Articles, Delayed Diagnosis Of Cancer, Diagnostic Errors, Failure To Diagnose, Medical Malpractice, Michael Glass, Michael Levine, Wrongful Death Claims|

It's named after a woman, Lavern Wilkinson, who died in 2013 of treatable lung cancer. Her radiologist noticed a suspicious mass in 2010, but Lavern was never told. When she went back more than 2½ later for a chronic cough, she was told she had cancer, that it had spread, and that it was terminal.